EFFICACY, SAFETY, AND TIME TO RESPONSE OF LINACLOTIDE IN PATIENTS ≥ 65 WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION

被引：0
|
作者：
Chang, Lin
Brenner, Darren M.
Chen, Wendy
Yerneni, Niha
Wu, James
Feuerstadt, Paul
Staller, Kyle
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1653
引用
收藏
页码：S1366 / S1366
页数：1
相关论文
共 50 条
  • [41] The Effect of Comorbid Psychological Distress on Baseline Irritable Bowel Syndrome With Constipation Symptoms and Response to Linaclotide Treatment
    Chey, William D.
    Spiegel, Brennan M.
    Lavins, Bernard J.
    Hao, Xinming
    Currie, Mark G.
    Schneier, Harvey
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S301 - S301
  • [42] Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide
    Yu, Siegfried W. B.
    Rao, Satish S. C.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2014, 7 (05): : 193 - 205
  • [43] Efficacy of Linaclotide in Improving Abdominal Symptoms Rated as Most Severe by Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
    Rao, Satish S.
    Quigley, Eamonn M.
    Shiff, Steven J.
    Lavins, Bernard J.
    Kurtz, Caroline B.
    MacDougall, James E.
    Shi, Kelvin
    Schneier, Harvey
    Currie, Mark G.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S144 - S144
  • [44] 26-WEEK EFFICACY AND SAFETY OF ONCE-DAILY ORAL LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): A EUROPEAN PERSPECTIVE
    Lembo, A. J.
    Fortea, J.
    Diaz, C.
    Falques, M.
    Shao, J. Z.
    Lavins, B. J.
    Schneier, H. A.
    Johnston, J. M.
    GUT, 2012, 61 : A35 - A36
  • [45] Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
    Chey, William D.
    Sayuk, Gregory S.
    Bartolini, Wilmin
    Reasner, David S.
    Fox, Susan M.
    Bochenek, Wieslaw
    Boinpally, Ramesh
    Shea, Elizabeth
    Tripp, Kenneth
    Borgstein, Niels
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (02): : 354 - 361
  • [46] A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan
    Fukudo, Shin
    Miwa, Hiroto
    Nakajima, Atsushi
    Haruma, Ken
    Kosako, Masanori
    Nakagawa, Ayako
    Akiho, Hiraku
    Yamaguchi, Yusuke
    Johnston, Jeffrey M.
    Currie, Mark
    Kinoshita, Yoshikazu
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (12):
  • [47] Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
    Rey, Enrique
    Mearin, Fermin
    Alcedo, Javier
    Ciriza, Constanza
    Delgado-Aros, Silvia
    Freitas, Teresa
    Mascarenhas, Miguel
    Minguez, Miguel
    Santos, Javier
    Serra, Jordi
    ADVANCES IN THERAPY, 2017, 34 (03) : 587 - 598
  • [48] TWO YEARS ON LINACLOTIDE: TOLERABILITY AND TREATMENT SATISFACTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION WITH AND WITHOUT DIARRHOEA
    Schneier, H. A.
    Shiff, S. J.
    Hao, X.
    Chickering, J. G.
    Kurtz, C. B.
    Currie, M. G.
    Johnston, J. M.
    GUT, 2017, 66 : A274 - A274
  • [49] Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
    Enrique Rey
    Fermín Mearin
    Javier Alcedo
    Constanza Ciriza
    Silvia Delgado-Aros
    Teresa Freitas
    Miguel Mascarenhas
    Miguel Mínguez
    Javier Santos
    Jordi Serra
    Advances in Therapy, 2017, 34 : 587 - 598
  • [50] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Maria I. Vazquez-Roque
    Ernest P. Bouras
    Advances in Therapy, 2013, 30 : 203 - 211
12345